Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 96 entries
Sorted by: Best Match Show Resources per page
The complexity of concept-attainment.

The American journal of psychology

WALLACH L.
PMID: 14004672
Am J Psychol. 1962 Jun;75:277-83.

No abstract available.

Cite
WALLACH L. The complexity of concept-attainment. Am J Psychol. 1962;75:277-83
WALLACH, L. (1962). The complexity of concept-attainment. The American journal of psychology, 75277-83.
WALLACH, L. "The complexity of concept-attainment." The American journal of psychology vol. 75 (1962): 277-83.
WALLACH L. The complexity of concept-attainment. Am J Psychol. 1962 Jun;75:277-83. PMID: 14004672.
Copy Download .nbib Format: NLM
Nitric oxide-releasing NSAIDs: GI-safe antithrombotics.

IDrugs : the investigational drugs journal

Wallace JL, Del Soldato P, Cirino G, Muscará MN.
PMID: 16158351
IDrugs. 1999 Apr;2(4):321-6.

Aspirin is increasingly being used for long-term prophylaxis of myocardial infarction and stroke, but its use is limited by toxicity in the gastrointestinal tract. Even very low doses of aspirin can markedly increase the risk of gastrointestinal bleeding and...

Cite
Wallace JL, Del Soldato P, Cirino G, et al. Nitric oxide-releasing NSAIDs: GI-safe antithrombotics. IDrugs. 1999;2(4):321-6
Wallace, J. L., Del Soldato, P., Cirino, G., & Muscará, M. N. (1999). Nitric oxide-releasing NSAIDs: GI-safe antithrombotics. IDrugs : the investigational drugs journal, 2(4), 321-6.
Wallace, J L, et al. "Nitric oxide-releasing NSAIDs: GI-safe antithrombotics." IDrugs : the investigational drugs journal vol. 2,4 (1999): 321-6.
Wallace JL, Del Soldato P, Cirino G, Muscará MN. Nitric oxide-releasing NSAIDs: GI-safe antithrombotics. IDrugs. 1999 Apr;2(4):321-6. PMID: 16158351.
Copy Download .nbib Format: NLM
Structural variations within group 1 (Li-Cs)+ (2,2,6,6-tetramethyl-1-piperidinyloxy)- complexes made via metallic reduction of the nitroxyl radical.

Inorganic chemistry

Balloch L, Drummond AM, García-Alvarez P, Graham DV, Kennedy AR, Klett J, Mulvey RE, O'Hara CT, Rodger PJ, Rushworth ID.
PMID: 19459697
Inorg Chem. 2009 Jul 20;48(14):6934-44. doi: 10.1021/ic900609e.

Treatment of 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) with a group 1 metal (Li, Na, K, Rb, or Cs), resulted in the reduction of this important radical to the TEMPO(-) anion--the first examples of elemental-metal single electron reduction of the radical to its...

Cite
Balloch L, Drummond AM, García-Alvarez P, et al. Structural variations within group 1 (Li-Cs)+ (2,2,6,6-tetramethyl-1-piperidinyloxy)- complexes made via metallic reduction of the nitroxyl radical. Inorg Chem. 2009;48(14):6934-44doi: 10.1021/ic900609e.
Balloch, L., Drummond, A. M., García-Alvarez, P., Graham, D. V., Kennedy, A. R., Klett, J., Mulvey, R. E., O'Hara, C. T., Rodger, P. J., & Rushworth, I. D. (2009). Structural variations within group 1 (Li-Cs)+ (2,2,6,6-tetramethyl-1-piperidinyloxy)- complexes made via metallic reduction of the nitroxyl radical. Inorganic chemistry, 48(14), 6934-44. https://doi.org/10.1021/ic900609e
Balloch, Liam, et al. "Structural variations within group 1 (Li-Cs)+ (2,2,6,6-tetramethyl-1-piperidinyloxy)- complexes made via metallic reduction of the nitroxyl radical." Inorganic chemistry vol. 48,14 (2009): 6934-44. doi: https://doi.org/10.1021/ic900609e
Balloch L, Drummond AM, García-Alvarez P, Graham DV, Kennedy AR, Klett J, Mulvey RE, O'Hara CT, Rodger PJ, Rushworth ID. Structural variations within group 1 (Li-Cs)+ (2,2,6,6-tetramethyl-1-piperidinyloxy)- complexes made via metallic reduction of the nitroxyl radical. Inorg Chem. 2009 Jul 20;48(14):6934-44. doi: 10.1021/ic900609e. PMID: 19459697.
Copy Download .nbib Format: NLM
Structural elaboration of the surprising ortho-zincation of benzyl methyl ether.

Chemical communications (Cambridge, England)

Balloch L, Kennedy AR, Klett J, Mulvey RE, O'Hara CT.
PMID: 20234945
Chem Commun (Camb). 2010 Apr 07;46(13):2319-21. doi: 10.1039/b924791b. Epub 2010 Jan 20.

Breaking with convention, the reaction of the sodium zincate, [(TMEDA)Na(mu-TMP)(mu-(t)Bu)Zn((t)Bu)] with benzyl methyl ether (PhCH(2)OMe) produces exclusively an ortho-zincated intermediate [(TMEDA)Na(mu-TMP)(mu-C(6)H(4)CH(2)OMe)Zn((t)Bu)] instead of the expected "thermodynamic" alpha-metallated product.

Cite
Balloch L, Kennedy AR, Klett J, et al. Structural elaboration of the surprising ortho-zincation of benzyl methyl ether. Chem Commun (Camb). 2010;46(13):2319-21doi: 10.1039/b924791b.
Balloch, L., Kennedy, A. R., Klett, J., Mulvey, R. E., & O'Hara, C. T. (2010). Structural elaboration of the surprising ortho-zincation of benzyl methyl ether. Chemical communications (Cambridge, England), 46(13), 2319-21. https://doi.org/10.1039/b924791b
Balloch, Liam, et al. "Structural elaboration of the surprising ortho-zincation of benzyl methyl ether." Chemical communications (Cambridge, England) vol. 46,13 (2010): 2319-21. doi: https://doi.org/10.1039/b924791b
Balloch L, Kennedy AR, Klett J, Mulvey RE, O'Hara CT. Structural elaboration of the surprising ortho-zincation of benzyl methyl ether. Chem Commun (Camb). 2010 Apr 07;46(13):2319-21. doi: 10.1039/b924791b. Epub 2010 Jan 20. PMID: 20234945.
Copy Download .nbib Format: NLM
Lymphangitic metastasis of recurrent renal cell carcinoma to the contralateral lung causing lymphangitic carcinomatosis and respiratory symptoms.

Current oncology (Toronto, Ont.)

Wallach JB, McGarry T, Torres J.
PMID: 21331270
Curr Oncol. 2011 Jan;18(1):e35-7. doi: 10.3747/co.v18i1.647.

Renal cell carcinoma comprises 80%-85% of kidney malignancies. For early presentations, nephrectomy provides a high cure rate, but patients usually present at advanced stages, leading to poor outcomes. Even for patients without metastatic spread who undergo nephrectomy, metastatic recurrence...

Cite
Wallach JB, McGarry T, Torres J. Lymphangitic metastasis of recurrent renal cell carcinoma to the contralateral lung causing lymphangitic carcinomatosis and respiratory symptoms. Curr Oncol. 2011;18(1):e35-7doi: 10.3747/co.v18i1.647.
Wallach, J. B., McGarry, T., & Torres, J. (2011). Lymphangitic metastasis of recurrent renal cell carcinoma to the contralateral lung causing lymphangitic carcinomatosis and respiratory symptoms. Current oncology (Toronto, Ont.), 18(1), e35-7. https://doi.org/10.3747/co.v18i1.647
Wallach, J B, et al. "Lymphangitic metastasis of recurrent renal cell carcinoma to the contralateral lung causing lymphangitic carcinomatosis and respiratory symptoms." Current oncology (Toronto, Ont.) vol. 18,1 (2011): e35-7. doi: https://doi.org/10.3747/co.v18i1.647
Wallach JB, McGarry T, Torres J. Lymphangitic metastasis of recurrent renal cell carcinoma to the contralateral lung causing lymphangitic carcinomatosis and respiratory symptoms. Curr Oncol. 2011 Jan;18(1):e35-7. doi: 10.3747/co.v18i1.647. PMID: 21331270; PMCID: PMC3031363.
Copy Download .nbib Format: NLM
Key findings from a national enhanced HIV surveillance system: 2010 - 2012.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Tarasuk J, Ogunnaike-Cooke S, Archibald C, MacLean R, Bennett R, Kim J, Malloch L.
PMID: 29769871
Can Commun Dis Rep. 2014 Nov 20;40(18):397-407. doi: 10.14745/ccdr.v40i18a05. eCollection 2014 Nov 20.

BACKGROUND: People who inject drugs represent an important risk group in Canada's HIV epidemic. I-Track is a national public health surveillance system designed to monitor HIV and hepatitis C prevalence and associated risk behaviour factors among people who inject...

Cite
Tarasuk J, Ogunnaike-Cooke S, Archibald C, et al. Key findings from a national enhanced HIV surveillance system: 2010 - 2012. Can Commun Dis Rep. 2014;40(18):397-407doi: 10.14745/ccdr.v40i18a05.
Tarasuk, J., Ogunnaike-Cooke, S., Archibald, C., MacLean, R., Bennett, R., Kim, J., Malloch, L. (2014). Key findings from a national enhanced HIV surveillance system: 2010 - 2012. Canada communicable disease report = Releve des maladies transmissibles au Canada, 40(18), 397-407. https://doi.org/10.14745/ccdr.v40i18a05
Tarasuk, J, et al. "Key findings from a national enhanced HIV surveillance system: 2010 - 2012." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 40,18 (2014): 397-407. doi: https://doi.org/10.14745/ccdr.v40i18a05
Tarasuk J, Ogunnaike-Cooke S, Archibald C, MacLean R, Bennett R, Kim J, Malloch L. Key findings from a national enhanced HIV surveillance system: 2010 - 2012. Can Commun Dis Rep. 2014 Nov 20;40(18):397-407. doi: 10.14745/ccdr.v40i18a05. eCollection 2014 Nov 20. PMID: 29769871; PMCID: PMC5933856.
Copy Download .nbib Format: NLM
Commentary: The challenge of evaluating and improving evidence when research lacks reproducibility.

International journal of epidemiology

Wallach JD, Basu S.
PMID: 28161710
Int J Epidemiol. 2016 Dec 01;45(6):2171-2172. doi: 10.1093/ije/dyw338.

No abstract available.

Cite
Wallach JD, Basu S. Commentary: The challenge of evaluating and improving evidence when research lacks reproducibility. Int J Epidemiol. 2016;45(6):2171-2172doi: 10.1093/ije/dyw338.
Wallach, J. D., & Basu, S. (2016). Commentary: The challenge of evaluating and improving evidence when research lacks reproducibility. International journal of epidemiology, 45(6), 2171-2172. https://doi.org/10.1093/ije/dyw338
Wallach, Joshua D, and Basu, Sanjay. "Commentary: The challenge of evaluating and improving evidence when research lacks reproducibility." International journal of epidemiology vol. 45,6 (2016): 2171-2172. doi: https://doi.org/10.1093/ije/dyw338
Wallach JD, Basu S. Commentary: The challenge of evaluating and improving evidence when research lacks reproducibility. Int J Epidemiol. 2016 Dec 01;45(6):2171-2172. doi: 10.1093/ije/dyw338. PMID: 28161710.
Copy Download .nbib Format: NLM
Meta-analysis Metastasis.

JAMA internal medicine

Wallach JD.
PMID: 31355868
JAMA Intern Med. 2019 Nov 01;179(11):1594-1595. doi: 10.1001/jamainternmed.2019.2999.

No abstract available.

Cite
Wallach JD. Meta-analysis Metastasis. JAMA Intern Med. 2019;179(11):1594-1595doi: 10.1001/jamainternmed.2019.2999.
Wallach, J. D. (2019). Meta-analysis Metastasis. JAMA internal medicine, 179(11), 1594-1595. https://doi.org/10.1001/jamainternmed.2019.2999
Wallach, Joshua D. "Meta-analysis Metastasis." JAMA internal medicine vol. 179,11 (2019): 1594-1595. doi: https://doi.org/10.1001/jamainternmed.2019.2999
Wallach JD. Meta-analysis Metastasis. JAMA Intern Med. 2019 Nov 01;179(11):1594-1595. doi: 10.1001/jamainternmed.2019.2999. PMID: 31355868.
Copy Download .nbib Format: NLM
An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014-2017).

Royal Society open science

Hardwicke TE, Wallach JD, Kidwell MC, Bendixen T, Crüwell S, Ioannidis JPA.
PMID: 32257301
R Soc Open Sci. 2020 Feb 19;7(2):190806. doi: 10.1098/rsos.190806. eCollection 2020 Feb.

Serious concerns about research quality have catalysed a number of reform initiatives intended to improve transparency and reproducibility and thus facilitate self-correction, increase efficiency and enhance research credibility. Meta-research has evaluated the merits of some individual initiatives; however, this...

Cite
Hardwicke TE, Wallach JD, Kidwell MC, et al. An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014-2017). R Soc Open Sci. 2020;7(2):190806doi: 10.1098/rsos.190806.
Hardwicke, T. E., Wallach, J. D., Kidwell, M. C., Bendixen, T., Crüwell, S., & Ioannidis, J. P. A. (2020). An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014-2017). Royal Society open science, 7(2), 190806. https://doi.org/10.1098/rsos.190806
Hardwicke, Tom E, et al. "An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014-2017)." Royal Society open science vol. 7,2 (2020): 190806. doi: https://doi.org/10.1098/rsos.190806
Hardwicke TE, Wallach JD, Kidwell MC, Bendixen T, Crüwell S, Ioannidis JPA. An empirical assessment of transparency and reproducibility-related research practices in the social sciences (2014-2017). R Soc Open Sci. 2020 Feb 19;7(2):190806. doi: 10.1098/rsos.190806. eCollection 2020 Feb. PMID: 32257301; PMCID: PMC7062098.
Copy Download .nbib Format: NLM
Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ.

ACS omega

Fief CA, Hoang KG, Phipps SD, Wallace JL, Deweese JE.
PMID: 31459613
ACS Omega. 2019 Feb 22;4(2):4049-4055. doi: 10.1021/acsomega.8b03428. eCollection 2019 Feb 28.

Fluoroquinolones are a class of widely prescribed antibiotics with a broad range of activity against Gram-positive, Gram-negative, and some atypical microbes. Unfortunately, these drugs are associated with significant adverse events including neuropathy, tendinopathy, cardiac rhythm abnormalities, and mental health...

Cite
Fief CA, Hoang KG, Phipps SD, et al. Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ. ACS Omega. 2019;4(2):4049-4055doi: 10.1021/acsomega.8b03428.
Fief, C. A., Hoang, K. G., Phipps, S. D., Wallace, J. L., & Deweese, J. E. (2019). Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ. ACS omega, 4(2), 4049-4055. https://doi.org/10.1021/acsomega.8b03428
Fief, Cole A, et al. "Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ." ACS omega vol. 4,2 (2019): 4049-4055. doi: https://doi.org/10.1021/acsomega.8b03428
Fief CA, Hoang KG, Phipps SD, Wallace JL, Deweese JE. Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ. ACS Omega. 2019 Feb 22;4(2):4049-4055. doi: 10.1021/acsomega.8b03428. eCollection 2019 Feb 28. PMID: 31459613; PMCID: PMC6648947.
Copy Download .nbib Format: NLM
Characteristics of available studies and dissemination of research using major clinical data sharing platforms.

Clinical trials (London, England)

Vazquez E, Gouraud H, Naudet F, Gross CP, Krumholz HM, Ross JS, Wallach JD.
PMID: 34407656
Clin Trials. 2021 Dec;18(6):657-666. doi: 10.1177/17407745211038524. Epub 2021 Aug 18.

BACKGROUND/AIMS: Over the past decade, numerous data sharing platforms have been launched, providing access to de-identified individual patient-level data and supporting documentation. We evaluated the characteristics of prominent clinical data sharing platforms, including types of studies listed as available...

Cite
Vazquez E, Gouraud H, Naudet F, et al. Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clin Trials. 2021;18(6):657-666doi: 10.1177/17407745211038524.
Vazquez, E., Gouraud, H., Naudet, F., Gross, C. P., Krumholz, H. M., Ross, J. S., & Wallach, J. D. (2021). Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clinical trials (London, England), 18(6), 657-666. https://doi.org/10.1177/17407745211038524
Vazquez, Enrique, et al. "Characteristics of available studies and dissemination of research using major clinical data sharing platforms." Clinical trials (London, England) vol. 18,6 (2021): 657-666. doi: https://doi.org/10.1177/17407745211038524
Vazquez E, Gouraud H, Naudet F, Gross CP, Krumholz HM, Ross JS, Wallach JD. Characteristics of available studies and dissemination of research using major clinical data sharing platforms. Clin Trials. 2021 Dec;18(6):657-666. doi: 10.1177/17407745211038524. Epub 2021 Aug 18. PMID: 34407656; PMCID: PMC8595516.
Copy Download .nbib Format: NLM
Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer.

Cureus

Aslam HM, Zhi C, Wallach SL.
PMID: 31007982
Cureus. 2019 Feb 07;11(2):e4024. doi: 10.7759/cureus.4024.

Tumor lysis syndrome (TLS) is a fatal complication of chemotherapy treatment. It is rarely seen in the treatment of solid tumors particularly in breast cancer. We presented the case of a chemo-naïve 58-year-old Caucasian woman who developed tumor lysis...

Cite
Aslam HM, Zhi C, Wallach SL. Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer. Cureus. 2019;11(2):e4024doi: 10.7759/cureus.4024.
Aslam, H. M., Zhi, C., & Wallach, S. L. (2019). Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer. Cureus, 11(2), e4024. https://doi.org/10.7759/cureus.4024
Aslam, Hafiz M, et al. "Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer." Cureus vol. 11,2 (2019): e4024. doi: https://doi.org/10.7759/cureus.4024
Aslam HM, Zhi C, Wallach SL. Tumor Lysis Syndrome: A Rare Complication of Chemotherapy for Metastatic Breast Cancer. Cureus. 2019 Feb 07;11(2):e4024. doi: 10.7759/cureus.4024. PMID: 31007982; PMCID: PMC6453617.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 96 entries